Aliskiren as Add-On Therapy in the Treatment of Hypertensive Diabetic Patients Inadequately Controlled with Valsartan/HCT Combination: A Placebo-Controlled Study.

MLA

Drummond, W., et al. “Aliskiren as Add-On Therapy in the Treatment of Hypertensive Diabetic Patients Inadequately Controlled with Valsartan/HCT Combination: A Placebo-Controlled Study.” American Journal of Cardiovascular Drugs, vol. 11, no. 5, Sept. 2011, pp. 327–33. EBSCOhost, https://doi.org/10.2165/11591970-000000000-00000.

APA

Drummond, W., Sirenko, Y. M., Ramos, E., Baek, I., & Keefe, D. L. (2011). Aliskiren as Add-On Therapy in the Treatment of Hypertensive Diabetic Patients Inadequately Controlled with Valsartan/HCT Combination: A Placebo-Controlled Study. American Journal of Cardiovascular Drugs, 11(5), 327–333. https://doi.org/10.2165/11591970-000000000-00000

Chicago

Drummond, W., Y. M. Sirenko, E. Ramos, I. Baek, and D. L. Keefe. 2011. “Aliskiren as Add-On Therapy in the Treatment of Hypertensive Diabetic Patients Inadequately Controlled with Valsartan/HCT Combination: A Placebo-Controlled Study.” American Journal of Cardiovascular Drugs 11 (5): 327–33. doi:10.2165/11591970-000000000-00000.